Registration Successful...
null you have successfully logged registered and logged in

Text PROTECT to 59152 or click here to sign-up for DOSING reminders.

Text STOP to 59152 to opt out, or text HELP to get more information.

 
 

Don’t let a

“Welcome home!”

become a

“Welcome back.”

Help protect your baby from severe RSV disease with SYNAGIS

LEARN MORE

What is severe RSV disease?

A quick introduction

LEARN MORE

Support programs

Information, reminders, and financial support for parents like you

LEARN MORE

IMPORTANT PRODUCT INFORMATION

open isi

INDICATION

SYNAGIS, 50 mg and 100 mg for injection, is a prescription medication that is used to help prevent a serious lung disease caused by respiratory syncytial virus (RSV) in children:

  • born prematurely (at or before 35 weeks) and who are 6 months of age or less at the beginning of RSV season

IMPORTANT PRODUCT INFORMATION

INDICATION

SYNAGIS, 50 mg and 100 mg for injection, is a prescription medication that is used to help prevent a serious lung disease caused by respiratory syncytial virus (RSV) in children:

  • born prematurely (at or before 35 weeks) and who are 6 months of age or less at the beginning of RSV season
  • who have a chronic lung condition, called bronchopulmonary dysplasia (BPD), that needed medical treatment within the last 6 months, and who are 24 months of age or less at the beginning of RSV season
  • born with certain types of heart disease and who are 24 months of age or less at the beginning of RSV season

SYNAGIS contains man-made, disease-fighting proteins called antibodies. It is not known if SYNAGIS is safe and effective to treat the symptoms of RSV in a child who already has RSV. SYNAGIS is used to help prevent RSV disease. It is not known if SYNAGIS is safe and effective in children who are older than 24 months of age at the start of dosing.

IMPORTANT SAFETY INFORMATION

Who should not receive SYNAGIS?

Children should not receive SYNAGIS if they have ever had a severe allergic reaction to it. Signs and symptoms of a severe allergic reaction could include severe rash, hives, or itchy skin; swelling of the lips, tongue, or face; swelling of the throat, difficulty swallowing; difficult, rapid, or irregular breathing; bluish color of skin, lips, or under fingernails; muscle weakness or floppiness; unresponsiveness.

If your child has any of these signs or symptoms of a severe allergic reaction after getting SYNAGIS, call your child’s healthcare provider or get medical help right away.

Before your child receives SYNAGIS, tell your child’s healthcare provider about all of your child’s medical conditions, including if your child:

  • has ever had a reaction to SYNAGIS
  • has bleeding or bruising problems

SYNAGIS is given by injection. If your child has a problem with bleeding or bruises easily, an injection could cause a problem.

Tell your child’s healthcare provider about all the medicines your child takes, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of SYNAGIS?

Serious side effects include severe allergic reactions, which may happen after any injection of SYNAGIS and may be life-threatening or cause death. Call your child’s healthcare provider or get medical help right away if your child has any of the signs or symptoms of a serious allergic reaction. See "Who should not receive SYNAGIS?" for more information.

The most common side effects of SYNAGIS include fever and rash.

These are not all the possible side effects for SYNAGIS. For more information ask your child’s healthcare provider.

  • Please click here for full Prescribing Information for SYNAGIS, including Patient Information.

    To report suspected adverse reactions, contact Sobi North America at 1-866-773-5274 or the FDA at 1-800-FDA-1088.

  • backtotop
     
     

    Contact Us X

    AstraZeneca has transferred all rights to SYNAGIS (palivizumab) to another manufacturer, Swedish Orphan Biovitrum AB (SOBI), in January of 2019. If you need SYNAGIS support, please contact SYNAGIS CONNECT® at (866)-285-8419(866)-285-8419.

    All imagery is for illustrative purposes only.